SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-19-232454
Filing Date
2019-08-28
Accepted
2019-08-28 16:20:06
Documents
72
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-K d783135d10k.htm 10-K 783868
2 EX-23.1 d783135dex231.htm EX-23.1 2557
3 EX-31.1 d783135dex311.htm EX-31.1 10685
4 EX-31.2 d783135dex312.htm EX-31.2 10688
5 EX-32.1 d783135dex321.htm EX-32.1 3846
12 GRAPHIC g783135g0822023429773.jpg GRAPHIC 34538
13 GRAPHIC g783135g0822023430210.jpg GRAPHIC 27559
  Complete submission text file 0001193125-19-232454.txt   6075994

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT meip-20190630.xml EX-101.INS 1414972
7 XBRL TAXONOMY EXTENSION SCHEMA meip-20190630.xsd EX-101.SCH 48891
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE meip-20190630_cal.xml EX-101.CAL 46773
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE meip-20190630_def.xml EX-101.DEF 338878
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20190630_lab.xml EX-101.LAB 438201
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20190630_pre.xml EX-101.PRE 389583
Mailing Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-50484 | Film No.: 191062161
SIC: 2834 Pharmaceutical Preparations